GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Traditional Chinese Medicine Holdings Co Ltd (HKSE:00570) » Definitions » PE Ratio

China Traditional Chinese Medicine Holdings Co (HKSE:00570) PE Ratio : 11.87 (As of Dec. 11, 2024)


View and export this data going back to 1993. Start your Free Trial

What is China Traditional Chinese Medicine Holdings Co PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-12-11), China Traditional Chinese Medicine Holdings Co's share price is HK$2.35. China Traditional Chinese Medicine Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.20. Therefore, China Traditional Chinese Medicine Holdings Co's PE Ratio for today is 11.87.

During the past 13 years, China Traditional Chinese Medicine Holdings Co's highest PE Ratio was 36.05. The lowest was 5.77. And the median was 15.40.

China Traditional Chinese Medicine Holdings Co's EPS (Diluted) for the six months ended in Jun. 2024 was HK$0.05. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.20.

As of today (2024-12-11), China Traditional Chinese Medicine Holdings Co's share price is HK$2.35. China Traditional Chinese Medicine Holdings Co's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.22. Therefore, China Traditional Chinese Medicine Holdings Co's PE Ratio without NRI ratio for today is 10.93.

During the past 13 years, China Traditional Chinese Medicine Holdings Co's highest PE Ratio without NRI was 37.56. The lowest was 5.77. And the median was 15.45.

China Traditional Chinese Medicine Holdings Co's EPS without NRI for the six months ended in Jun. 2024 was HK$0.07. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.22.

During the past 12 months, China Traditional Chinese Medicine Holdings Co's average EPS without NRI Growth Rate was -7.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was -11.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was -6.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 7.60% per year.

During the past 13 years, China Traditional Chinese Medicine Holdings Co's highest 3-Year average EPS without NRI Growth Rate was 73.00% per year. The lowest was -19.70% per year. And the median was 14.30% per year.

China Traditional Chinese Medicine Holdings Co's EPS (Basic) for the six months ended in Jun. 2024 was HK$0.05. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.20.

Back to Basics: PE Ratio


China Traditional Chinese Medicine Holdings Co PE Ratio Historical Data

The historical data trend for China Traditional Chinese Medicine Holdings Co's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Traditional Chinese Medicine Holdings Co PE Ratio Chart

China Traditional Chinese Medicine Holdings Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.71 9.77 11.00 20.88 14.09

China Traditional Chinese Medicine Holdings Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss 20.88 At Loss 14.09 At Loss

Competitive Comparison of China Traditional Chinese Medicine Holdings Co's PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, China Traditional Chinese Medicine Holdings Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Traditional Chinese Medicine Holdings Co's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Traditional Chinese Medicine Holdings Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where China Traditional Chinese Medicine Holdings Co's PE Ratio falls into.



China Traditional Chinese Medicine Holdings Co PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

China Traditional Chinese Medicine Holdings Co's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=2.35/0.198
=11.87

China Traditional Chinese Medicine Holdings Co's Share Price of today is HK$2.35.
For company reported semi-annually, China Traditional Chinese Medicine Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.20.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


China Traditional Chinese Medicine Holdings Co  (HKSE:00570) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


China Traditional Chinese Medicine Holdings Co PE Ratio Related Terms

Thank you for viewing the detailed overview of China Traditional Chinese Medicine Holdings Co's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China Traditional Chinese Medicine Holdings Co Business Description

Traded in Other Exchanges
Address
288 Hennessy Road, Room 1601, Emperor Group Centre, Wanchai, Hong Kong, HKG
China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through four segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. It generates maximum revenue from the Yifang segment which mainly engages in the manufacture and sales of concentrated TCM granules (CTCMG), TCM healthcare products, and TCM decoction pieces under the Yi Fang brand. The majority of the revenue of the Yi Fang segment is derived from the sales of CTCMG. Geographically, it derives a majority of its revenue from Mainland China.
Executives
Ubs Group Ag 2201 Interest of corporation controlled by you
Wang Xiaochun 2201 Interest of corporation controlled by you
Ping An Life Insurance Company Of China, Ltd. 2101 Beneficial owner
Zhong Guo Ping An Bao Xian Ji Tuan Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhong Guo Yi Yao Ji Tuan Zong Gong Si 2201 Interest of corporation controlled by you

China Traditional Chinese Medicine Holdings Co Headlines

No Headlines